Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 41% ± 12% | |
lung | 17 studies | 49% ± 18% | |
intestine | 12 studies | 41% ± 22% | |
brain | 12 studies | 32% ± 13% | |
kidney | 9 studies | 48% ± 15% | |
eye | 9 studies | 37% ± 15% | |
lymph node | 6 studies | 47% ± 16% | |
liver | 6 studies | 43% ± 21% | |
pancreas | 5 studies | 56% ± 24% | |
bone marrow | 5 studies | 36% ± 18% | |
uterus | 5 studies | 56% ± 21% | |
placenta | 4 studies | 57% ± 24% | |
prostate | 4 studies | 40% ± 15% | |
breast | 4 studies | 53% ± 7% | |
adrenal gland | 3 studies | 37% ± 9% | |
esophagus | 3 studies | 47% ± 30% | |
skin | 3 studies | 36% ± 13% | |
thymus | 3 studies | 59% ± 27% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 12662.45 | 1445 / 1445 | 100% | 178.15 | 183 / 183 |
ovary | 100% | 43435.10 | 180 / 180 | 100% | 183.07 | 430 / 430 |
prostate | 100% | 14516.09 | 245 / 245 | 100% | 285.55 | 502 / 502 |
brain | 100% | 12601.45 | 2640 / 2642 | 100% | 314.44 | 705 / 705 |
breast | 100% | 17120.87 | 459 / 459 | 100% | 247.06 | 1117 / 1118 |
thymus | 100% | 13514.67 | 653 / 653 | 100% | 266.01 | 603 / 605 |
lung | 100% | 10931.73 | 576 / 578 | 100% | 208.22 | 1154 / 1155 |
uterus | 100% | 23399.29 | 170 / 170 | 100% | 186.90 | 457 / 459 |
kidney | 100% | 16844.15 | 89 / 89 | 100% | 251.84 | 897 / 901 |
skin | 100% | 13794.47 | 1808 / 1809 | 100% | 286.73 | 470 / 472 |
liver | 100% | 9359.99 | 226 / 226 | 100% | 177.06 | 404 / 406 |
pancreas | 99% | 8150.36 | 326 / 328 | 100% | 159.21 | 178 / 178 |
bladder | 100% | 17003.00 | 21 / 21 | 99% | 161.05 | 500 / 504 |
intestine | 100% | 14854.03 | 966 / 966 | 99% | 161.22 | 520 / 527 |
stomach | 100% | 11991.53 | 359 / 359 | 99% | 175.71 | 282 / 286 |
adrenal gland | 100% | 18844.93 | 258 / 258 | 97% | 175.78 | 224 / 230 |
adipose | 100% | 17910.84 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 16955.36 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 310.94 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 179.49 | 29 / 29 |
muscle | 100% | 19714.22 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7761.82 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 165.99 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 67.99 | 1 / 1 |
heart | 94% | 8518.64 | 810 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 7632.28 | 850 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006457 | Biological process | protein folding |
GO_0051085 | Biological process | chaperone cofactor-dependent protein refolding |
GO_0009617 | Biological process | response to bacterium |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0030544 | Molecular function | Hsp70 protein binding |
Gene name | ST13 |
Protein name | Hsc70-interacting protein (Hip) (Aging-associated protein 2) (Progesterone receptor-associated p48 protein) (Protein FAM10A1) (Putative tumor suppressor ST13) (Renal carcinoma antigen NY-REN-33) (Suppression of tumorigenicity 13 protein) ST13 protein ST13 Hsp70 interacting protein PRO0786 (ST13 protein) |
Synonyms | AAG2 HIP FAM10A1 SNC6 |
Description | FUNCTION: One HIP oligomer binds the ATPase domains of at least two HSC70 molecules dependent on activation of the HSC70 ATPase by HSP40. Stabilizes the ADP state of HSC70 that has a high affinity for substrate protein. Through its own chaperone activity, it may contribute to the interaction of HSC70 with various target proteins (By similarity). . |
Accessions | P50502 ENST00000413424.5 F8WAQ7 H7C3I1 ENST00000216218.8 Q3KNR6 ENST00000455824.1 ENST00000411695.1 F6VDH7 Q9P1I4 Q0IJ56 |